USPTO serial 79302185
EASY SYSTEM NG.BIOTECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 6, 2022
- Examiner
- LOOK, JEFFREY J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EASY SYSTEM NG.BIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
GUIPRY, F-35480 GUIPRY-MESSAC, FR
GUIPRY, F-35480 GUIPRY-MESSAC, FR
GUIPRY, F-35480 GUIPRY-MESSAC, FR
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, diagnostic and analytical test materials in the nature of in vitro diagnostic preparations and reagents for medical use for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; pharmaceutical preparations, namely, diagnostic and analytical test materials in the nature of in vitro diagnostic preparations and reagents for medical use for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; medical preparations in the nature of diagnostic preparations for medical purposes for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; sanitary preparations for medical purposes in the nature of diagnostic and analytical preparations for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; analytical medical diagnostic test kits in the immunoassay field consisting primarily of medical diagnostic test strips, and also medical devices for obtaining body fluid samples being test cassettes and midstream test cassettes, all for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; medical diagnostic reagents and assays for testing bodily fluids; material, preparations and reagents for diagnostic tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; medical diagnostic test strips for use in testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; material, preparations and reagents for rapid diagnostic guidance tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; material, preparations and reagents for serological tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; material, preparations and reagents for antigen detection tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy and the presence of hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; chemical reagents for medical use; pregnancy testing preparations and medical diagnostic reagents for pregnancy tests; home pregnancy test kits; medical diagnostic test kits comprised of medical diagnostic reagents for testing of body fluids and body samples for use in disease detection of Covid-19; medical diagnostic home testing kits comprised of medical diagnostic reagents and assays that test for the presence of Covid-19; none of the above-mentioned goods being anesthesia machines or intended for anesthesia machines | ACTIVE | — |
| 009 | Apparatus and instruments for the recording, transmission, reproduction or processing of data; mobile data-communication apparatus; wireless communications devices enabling data transmission; downloadable or recorded media, namely, downloadable or recorded digital multimedia files featuring medical data; digital recording media, namely, prerecorded downloadable audio and video recordings featuring medical data; downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical data; computer platforms in the form of recorded or downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical data; downloadable software for transmitting and managing data; downloadable application software for wireless devices for transmitting, reading, communicating, analyzing, managing and tracking medical data; downloadable software for measuring, detecting, monitoring and controlling medical data and medical diagnostic test results in the medical field; downloadable software for scheduling, conducting and monitoring therapeutic follow-up; downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results; downloadable software applications for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results; downloadable mobile applications for transmitting and managing data; downloadable mobile applications for measuring, detecting, monitoring and controlling medical data and medical diagnostic test results in the medical field; downloadable mobile applications for scheduling, conducting and monitoring therapeutic follow-up; downloadable mobile applications for transmitting, reading, communicating, analyzing, managing and tracking medical diagnosis test results; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; none of the abovementioned goods being anesthesia machines or intended for anesthesia machines | ACTIVE | — |
| 010 | Computerized medical analysis apparatus and instruments for analyzing medical diagnosis testing media to determine the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; medical instruments for testing for infectious diseases, namely, biosensors for detecting infectious diseases; computerized medical testing instruments for use in medical diagnosis, namely, wireless mobile readers specially adapted for analyzing medical diagnostic test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; laboratory apparatus for medical diagnosis, namely, computerized medical analysis apparatuses being wireless mobile readers specially adapted for analyzing medical diagnostic test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; apparatus for conducting diagnostic tests for medical use, namely, computerized medical analysis apparatuses being wireless mobile readers specially adapted for analyzing medical diagnostic test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; diagnostic apparatus for rapid diagnostic guidance tests, namely, computerized medical analysis apparatuses being wireless mobile readers specially adapted for analyzing medical diagnostic test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; diagnostic apparatus for serological testing for infectious diseases and Covid-19 antigens; diagnostic apparatus for testing and detecting infectious diseases and Covid-19 antigens; diagnostic apparatus for testing for pregnancy; diagnostic apparatus for Covid-19 detection tests; computerized medical analysis apparatus for reading of analytical tests, namely, wireless mobile readers specially adapted for analyzing medical diagnostic test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; none of the above-mentioned goods being anesthesia machines or intended for anesthesia machines | ACTIVE | — |
| 035 | Retail, wholesale and online retail store services for pharmaceutical products, namely, diagnostic and analytical test materials, preparations and reagents for medical use for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, pharmaceutical preparations, namely, diagnostic and analytical test materials, preparations and reagents for medical use for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, medical preparations in the nature of diagnostic and analytical preparations for medical purposes for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, sanitary preparations for medical purposes in the nature of diagnostic and analytical preparations for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, analytical tests in the immunoassay field, namely, test strips, test cassettes and midstream test cassettes for testing for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, medical diagnostic tests and reagents for analyzing body fluids, material, preparations and reagents for diagnostic tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, medical diagnostic test strips for use in testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, material, preparations and reagents for rapid diagnostic guidance tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, material, preparations and reagents for serological tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, material, preparations and reagents for antigen detection tests for medical use, namely, medical diagnostic reagents and assays for testing body fluids and body samples for pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, chemical reagents for medical use, pregnancy testing preparations and medical diagnostic reagents for pregnancy tests, home pregnancy test kits, medical diagnostic test kits comprised of medical diagnostic reagents for testing of body fluids and body samples for use in disease detection of Covid-19, medical diagnostic home testing kits comprised of medical diagnostic reagents and assays that test for the presence of Covid-19, apparatus and instruments for the recording, transmission, reproduction or processing of data, mobile data communications apparatus, wireless communications devices enabling data transmission, downloadable or recorded media, namely, downloadable or recorded digital files featuring medical data, digital recording media, namely, pre-recorded downloadable audio and video recordings featuring medical data, downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical data, computer platforms in the form of recorded or downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical data, downloadable software for transmitting and managing data, downloadable application software for wireless devices for transmitting, reading, communicating, analyzing, managing and tracking medical data, downloadable software for measuring, detecting, monitoring and controlling medical data and medical diagnostic test results in the medical field, downloadable software for scheduling, conducting and monitoring therapeutic follow-up, downloadable software for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results, downloadable software applications for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results, downloadable mobile applications for transmitting and managing data, downloadable mobile applications for measuring, detecting, monitoring and controlling medical data and medical diagnostic test results in the medical field, downloadable mobile applications for scheduling, conducting and monitoring therapeutic follow-up, downloadable mobile applications for transmitting, reading, communicating, analyzing, managing and tracking medical diagnostic test results, research laboratory analyzers for measuring, testing and analyzing of blood and other bodily fluids, medical apparatus and instruments for reading test results from diagnostic and analytical tests for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, medical instruments for testing for infectious diseases, namely, biosensors for detecting infectious diseases, medical testing instruments for use in medical diagnosis, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, laboratory apparatus for medical diagnosis, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, apparatus for conducting diagnostic tests for medical use, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, diagnostic apparatus for rapid diagnostic guidance tests, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19, diagnostic apparatus for serological testing for infectious diseases and Covid-19 antigens, diagnostic apparatus for testing and detecting infectious diseases and Covid-19 antigens , diagnostic apparatus for testing for pregnancy, diagnostic apparatus for Covid-19 detection tests, medical apparatus for reading of analytical tests, namely, wireless mobile readers for reading test results from test devices, test strips, test cassettes and midstream test cassettes for the presence of pregnancy, hormones, proteins, antibodies, antigens, pathogens, viruses, bacteria, parasites, infectious diseases, antibiotic resistance, antimicrobial resistance, immunity, drugs and Covid-19; commercial business management; commercial administration of the licensing of the goods and services of others; office functions; advertising; online advertising; publication of advertising texts; dissemination of advertisements; dissemination of advertising material, namely, leaflets, flyers, prospectuses, printed matter, brochures, and samples; rental of advertising space and advertising material; rental of advertising time on all means of communication media; direct mail advertising services; presentation of goods on all communication media, for retail purposes; providing commercial shopping information and advice for consumers in the choice of products and services; organization of exhibitions, fairs, events, trade fairs for commercial or advertising purposes; product presentation and demonstration services for commercial or advertising purposes; market study; collection, processing and systematization of data, for humans; data management services for use in debt collection, namely, electronic data collection and on-line claims management; transcription of data; services involving the transcription of statistical data; database management; computer file management; collection, compilation and systemization of information into computer databases; all the aforementioned services in connection with medical and veterinary diagnostic tests; none of the above-mentioned services being related to anesthesia machines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NG BIOTECH
- Other trademarks owned by NG BIOTECH
- Other trademarks owned by NG BIOTECH
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Similar marks named EASY SYSTEM NG.BIOTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 9, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 12, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 22, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 21, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 6, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 6, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 6, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 10, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 20, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 20, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 7, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 7, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 31, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 28, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 27, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 4, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 15, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 15, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 15, 2022 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Feb 15, 2022 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Feb 15, 2022 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Feb 15, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 15, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 15, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 20, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 20, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 20, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 20, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 20, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 20, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 20, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 23, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 23, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 14, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 19, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |